À PROPOS DE CET ÉPISODE
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the emerging role of antibody-drug conjugates (ADCs) in the treatment of patients with non-small cell lung cancer (NSCLC), including the mechanistic rationale and role of biomarkers in patient selection, the latest efficacy and safety data, and dose-finding strategies for optimal use in NSCLC.
The experts:
- Prof. Jarushka Naidoo, Beaumont RCSI Cancer Centre, Dublin, Ireland
- Dr Rebecca Heist, Massachusetts General Hospital Cancer Center, Boston, MA, USA
- Dr Antonio Passaro, European Institute of Oncology, Milan, Italy
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is provided by touchIME.
For further information please visit: https://touchoncology.com/education/pd-navigating-the-nsclc-treatment-pathway-focus-on-adcs/
Anglais
États-Unis
TRANSCRIPTION 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
RECHERCHER LES ÉPISODES PASSÉS
Rechercher les épisodes précédents de touchPODCAST.
AUTRES ÉPISODES DANS CE PODCAST
touchMDT for touchIMMUNOLOGY, touchHEMATOLOGY, touchDERMATOLOGY, and touchONCOLOGY
Listen to key experts from a multidisciplinary team discuss the diagnosis, classification, and management of patients with systemic mastocytosis. They provide their key insights on effectively recognizing systemic m…
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss the medical and surgical decision-making challenges in perineal and genital HS, including common diagnostic pitfalls, how to integrate medical and surgical treatment, and the unique role of urology in managing complex disea…
Dr. Melinda Gooderham, Prof. Dr. Falk Bechara, and Dr. Daniel Stein discuss how evolving therapies are reshaping HS management and multidisciplinary care, with patient perspectives highlighting the impact of coordinated care and effective disease control.
The multidisciplinary team
Dr. Melinda …
touchEXPERT FOCUS for touchNEUROLOGY, touchIMMUNOLOGY, touchOPHTHALMOLOGY
Dr. Eoin Flanagan shares his expert insights on myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and how to distinguish it from other demyelinating diseases like multiple sclerosis (MS) and aquapor…
touchEXPERT FOCUS for touchINFECTIOUS DISEASES
Listen to a series of short interviews with three leading experts discussing preference-sensitive care for people living with HIV. Faculty consider the evolving landscape of simplified ART options, including long-acting injectable regimens, and provid…
Avertissement: Le podcast et les illustrations intégrés sur cette page proviennent de touchpodcast, qui est la propriété de son propriétaire et n'est ni affilié ni approuvé par Listen Notes, Inc.
MODIFIER
Merci de nous avoir aidé à tenir la base de données de podcasts à jour.
